XML 48 R36.htm IDEA: XBRL DOCUMENT

EMPLOYEE STOCK COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2020

Share-based Payment Arrangement [Abstract]

Summary of Share-Based Compensation Expense

The following table presents stock-based compensation expense and the related tax benefits for the periods indicated:


	Three Months Ended June 30,						Six Months Ended June 30,
($ in thousands)	2020		2019		2020		2019
Stock options	$	2	$	(24)	$	4	$	(16)
Restricted stock awards and units	1,468		1,521		3,042		2,366

Total share-based compensation expense	$	1,470	$	1,497	$	3,046	$	2,350
Related tax benefits	$	433	$	440	$	897	$	691

Unrecognized Share-Based Compensation Expense

The following table presents unrecognized stock-based compensation expense as of June 30, 2020:

($ in thousands)

Unrecognized Expense

Weighted-Average Remaining Expected Recognition Period

Restricted stock awards and restricted stock units

9,530

2.3 years

Total

9,530

2.3 years

Option Activity

The following table represents stock option activity for the three months ended June 30, 2020:


	Three Months Ended June 30, 2020
($ in thousands except per share data)	Number of Shares	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contract Term	Aggregated Intrinsic Value
Outstanding at beginning of period	55,069	$	13.96	4.0 years





Outstanding at end of period	55,069	$	13.96	3.7 years	$	(194)
Exercisable at end of period	52,821	$	13.97	3.6 years	$	(187)

The following table represents stock option activity for the six months ended June 30, 2020:


	Six Months Ended June 30, 2020
($ in thousands except per share data)	Number of Shares	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contract Term	Aggregated Intrinsic Value
Outstanding at beginning of period	62,521	$	13.85	4.3 years


Exercised	(7,452)	$	13.05	5.2 years


Outstanding at end of period	55,069	$	13.96	3.7 years	$	(194)
Exercisable at end of period	52,821	$	13.97	3.6 years	$	(187)

Nonvested Share Activity

The following table sets forth information regarding unvested stock options for the three and six months ended June 30, 2020:


	Three Months Ended June 30, 2020				Six Months Ended June 30, 2020
	Number of Shares	Weighted-Average Exercise Price Per Share		Number of Shares	Weighted-Average Exercise Price Per Share
Outstanding at beginning of period	2,248	$	13.75	2,248	$	13.75

Vested	—	$	—	—	$	—
Forfeited	—	$	—	—	$	—
Outstanding at end of period	2,248	$	13.75	2,248	$	13.75

Restricted Stock and Restricted Stock Units Activity

The following table presents unvested restricted stock awards and restricted stock units activity for the three and six months ended June 30, 2020:


	Three Months Ended June 30, 2020				Six Months Ended June 30, 2020
	Number of Shares	Weighted Average Grant Date Fair Value Per Share		Number of Shares	Weighted Average Grant Date Fair Value Per Share
Outstanding at beginning of period	1,083,107	$	15.65	923,482	$	15.74
Granted ⁽¹⁾	84,998	$	8.76	354,136	$	13.79
Vested ⁽²⁾	(231,362)	$	16.09	(293,695)	$	15.95
Forfeited ⁽³⁾	(24,073)	$	18.20	(71,253)	$	16.85
Outstanding at end of period	912,670	$	14.91	912,670	$	14.91

(1)There were zero and 78,771 performance-based shares/units included in shares granted for the three and six months ended June 30, 2020.

(2)There were 13,074 and 18,473 performance-based shares/units included in vested shares for the three and six months ended June 30, 2020.

(3)The number of forfeited shares includes aggregate performance-based shares/units of 1,782 and 17,404 for the three and six months ended June 30, 2020.

Summary of all Outstanding SARs

The following table represents SARs activity and the weighted average exercise price per share as of and for the three months ended June 30, 2020:


	Three Months Ended June 30, 2020
($ in thousands except per share data)	Number of Shares	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contract Term	Aggregated Intrinsic Value
Outstanding at beginning of period	1,559,012	$	11.60	2.4 years	$	(5,616)



Outstanding at end of period	1,559,012	$	11.60	2.1 years	$	(1,812)
Exercisable at end of period	1,559,012	$	11.60	2.1 years	$	(1,812)

The following table represents SARs activity and the weighted average exercise price per share as of and for the six months ended June 30, 2020:


	Six Months Ended June 30,
($ in thousands except per share data)	Number of Shares	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contract Term	Aggregated Intrinsic Value
Outstanding at beginning of period	1,559,012	$	11.60	2.6 years	$	8,508



Outstanding at end of period	1,559,012	$	11.60	2.1 years	$	(1,812)
Exercisable at end of period	1,559,012	$	11.60	2.1 years	$	(1,812)